Statin-use, lipids and HMG-CoA reductase inhibition on risk of idiopathic pulmonary fibrosis

Sizheng Steven Zhao; Philip  Alton; Kira  Rogers; David M. Hughes

Statin-use, lipids and HMG-CoA reductase inhibition on risk of idiopathic pulmonary fibrosis

Sizheng Steven Zhao, Philip Alton, Kira Rogers, David M. Hughes

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

2 Downloads (Pure)

Original language	English
Journal	Clinical Therapeutics
Publication status	Accepted/In press - 24 Oct 2023

Keywords

idiopathic pulmonary fibrosis
LDL cholesterol
statins
Mendelian randomization
HMG-CoA reductase

Access to Document

statin IPF_R1_cleanAccepted author manuscript, 255 KBLicence: CC BY

1 Finished
1 Active

Centre for Epidemiology Versus Arthritis.
Dixon, W. (PI), Bruce, I. (CoI), Felson, D. (CoI), Hyrich, K. (CoI), Lunt, M. (CoI), Mcbeth, J. (CoI), Mcdonagh, J. (CoI), O'Neill, T. (CoI), Sergeant, J. (CoI), Verstappen, S. (CoI) & Serafimova, I. (Support team)
1/08/18 → 31/07/25
Project: Research
Stratification of Psoriasis Patients at High Risk of Psoriatic Arthritis Using Lifestyle, Environment and Genetic Factors.
Bowes, J. (PI), Barton, A. (CoI), Dixon, W. (CoI) & Sergeant, J. (CoI)
1/06/16 → 30/06/19
Project: Research

Cite this

@article{6f776f6c89f7410fb017b2a6a2b7b631,

title = "Statin-use, lipids and HMG-CoA reductase inhibition on risk of idiopathic pulmonary fibrosis",

keywords = "idiopathic pulmonary fibrosis, LDL cholesterol, statins, Mendelian randomization, HMG-CoA reductase",

author = "Zhao, {Sizheng Steven} and Philip Alton and Kira Rogers and Hughes, {David M.}",

year = "2023",

month = oct,

day = "24",

language = "English",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Statin-use, lipids and HMG-CoA reductase inhibition on risk of idiopathic pulmonary fibrosis

AU - Zhao, Sizheng Steven

AU - Alton, Philip

AU - Rogers, Kira

AU - Hughes, David M.

PY - 2023/10/24

Y1 - 2023/10/24

KW - idiopathic pulmonary fibrosis

KW - LDL cholesterol

KW - statins

KW - Mendelian randomization

KW - HMG-CoA reductase

M3 - Article

SN - 0149-2918

JO - Clinical Therapeutics

JF - Clinical Therapeutics

ER -

Statin-use, lipids and HMG-CoA reductase inhibition on risk of idiopathic pulmonary fibrosis

Keywords

Access to Document

Projects

Centre for Epidemiology Versus Arthritis.

Stratification of Psoriasis Patients at High Risk of Psoriatic Arthritis Using Lifestyle, Environment and Genetic Factors.

Cite this